Opinion: The military’s medical corps has a serious recruitment problem
Congress must incentivize more physicians (and their employers) to join the military medical corps, writes the former attending physician to Congress.
Read full article →Medicare Monitor
Tracking Medicare news, policy, and coverage changes.
Confirmed Ebola cases in Congo reach 282 as survivors describe their recoveries
The outbreak remains focused in Congo's eastern Ituri province. Congo has reported over 1,000 suspected cases with the Bundibugyo virus, which has no approved treatment or vaccine.
Read full article →Is bovine colostrum really 'liquid gold' for gut health?
Baby calves rely on it to build up their immune systems and gut. And now marketers are promoting it for humans. Here's what scientists say.
Read full article →Beyond the clinical note: why the next decade of EHR success is financial
Why EHR success is shifting from clinical notes to owning the "financial layer" of the practice.
Read full article →How long does hospital credentialing take? The quiet cost of provider readiness delays
Patients can’t wait — but provider credentialing delays are getting longer.
Read full article →Why Ob-Gyns, States, and Plans, Should Care About Oral Health
While there are growing efforts to link dental health with overall health, the urgency should be felt strongly not only by pregnant women but, more importantly, by their care providers and health insurance companies. For instance, pregnant women with gum disease are 3-4 times more likely to develop pre-eclampsia, an emergency condition. The post Why Ob-Gyns, States, and Plans, Should Care About Oral Health appeared first on MedCity News .
Read full article →Regeneron Cancer Drug Shows New Promise in a Rare Disease… and Maybe More
Regeneron Pharmaceuticals’ multiple myeloma drug linvoseltamab has clinical trial results showing complete responses in 90% of patients who have light chain amyloidosis, a rare blood disease. The preliminary data were presented during the annual meeting of the American Society of Clinical Oncology. The post Regeneron Cancer Drug Shows New Promise in a Rare Disease… and Maybe More appeared first on MedCity News .
Read full article →Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom’s over-the-counter CGM with an app that translates glucose data into personalized diet and lifestyle recommendations. The post Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss appeared first on MedCity News .
Read full article →STAT+: A standing ovation for RevMed, and caution for Akeso
ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.
Read full article →How aid cuts are hampering the frontline response to the Ebola crisis
Aid workers in Uganda are watching the Ebola crisis unfold in the neighboring Democratic Republic of Congo. They're doing what they can to prepare for an uptick in cases, but foreign aid cuts aren't helping.
Read full article →Practice-Changing Trial in Prostate Cancer Shows Benefits of Perioperative Therapy
(MedPage Today) -- CHICAGO -- A paradigm-changing clinical trial in prostate cancer showed that perioperative apalutamide (Erleada) and androgen deprivation therapy (ADT) significantly reduced the risk of metastasis in high-risk localized disease...
Read full article →'The Light Goes Out of Their Eyes in About 3 Years': What We Heard This Week
(MedPage Today) -- "The light goes out of their eyes in about 3 years. This is not what they signed up for." -- Clark Coler, MD, of Swedish Medical Group in Seattle, on young physicians facing the increasingly profit-driven demands of modern...
Read full article →